Substance
GUSELKUMAB
Global reference: every product and company linked to this substance.
- cas: 1350289-85-8
- ncit: C150390
- rxnorm: 1928588
- unii: 089658A12D
CNTO 1959 · CNTO-1959 · guselkumab [INN] · GUSELKUMAB [JAN] · GUSELKUMAB [USAN] · Guselkumab [WHO-DD] · TREMFYA
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | TREMFYA | Q2 2026 | $2.0B |
| JOHNSON & JOHNSON COMMON STOCK | TREMFYA | Q2 2026 | $2.0B |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- TREMFYA · JOHNSON & JOHNSON COMMON STOCK
- TREMFYA · JOHNSON & JOHNSON COMMON STOCK